Vimarsana
Biggest News Aggregation in the World

E3 2022 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from E3 2022. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In E3 2022 Today - Breaking & Trending Today

Armata Pharmaceuticals Inc (ARMP) Reports Q3 2023 Financial Results and Corporate Updates - Vimarsana News

Armata Pharmaceuticals Inc (ARMP) Reports Q3 2023 Financial Results and Corporate Updates

Continued Progress in Phage Therapeutics Development Amidst Increased Expenses

Source: yahoo.com
UroGen Pharma Ltd (URGN) Reports Growth in Q3 Revenue and Progress in Clinical Trials - Vimarsana News

UroGen Pharma Ltd (URGN) Reports Growth in Q3 Revenue and Progress in Clinical Trials

Net Revenue Rises as Company Advances with UGN-102 Clinical Development

Source: yahoo.com
Sanara MedTech Inc. Reports Record Sales in Q3 2023 with Narrowed Net Loss and Positive ... - Vimarsana News

Sanara MedTech Inc. Reports Record Sales in Q3 2023 with Narrowed Net Loss and Positive ...

Strategic Acquisitions and Product Launches Propel Growth Amidst Operational Challenges

Source: yahoo.com
electroCore Inc (ECOR) Reports Substantial Sales Growth in Q3 2023 - Vimarsana News

electroCore Inc (ECOR) Reports Substantial Sales Growth in Q3 2023

Net Sales Surge by 128% Year-Over-Year; Company Raises Full-Year Revenue Guidance

Source: yahoo.com
Fulcrum Therapeutics Inc (FULC) Reports Q3 2023 Financial Results and Business Highlights - Vimarsana News

Fulcrum Therapeutics Inc (FULC) Reports Q3 2023 Financial Results and Business Highlights

Company's cash runway extended into 2026, with a net loss of $24.0 million for Q3 2023

Source: yahoo.com